Education: An overview from the author of 'Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients'.
Marco FalconePublished in: JAC-antimicrobial resistance (2021)
This video is a presentation from Professor Marco Falcone from the University Hospital Pisa, Italy, originally presented at the BSAC conference 'Into clinical practice: Meeting the challenges of Gram-negative infection management' on 14 October 2020. Professor Falcone highlights the cefiderocol compassionate use case series that has been published in Clinical Infectious Diseases (Falcone M, Tiseo G, Nicastro M et al. Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients. Clin Infect Dis 2020; doi: 10.1093/cid/ciaa1410).
Keyphrases
- gram negative
- multidrug resistant
- acinetobacter baumannii
- drug resistant
- intensive care unit
- end stage renal disease
- newly diagnosed
- ejection fraction
- pseudomonas aeruginosa
- clinical practice
- prognostic factors
- peritoneal dialysis
- healthcare
- infectious diseases
- systematic review
- randomized controlled trial
- acute respiratory distress syndrome
- meta analyses